Dr. González-Cabo has a degree in Biological Sciences, with specialty in Biochemistry, from the University of Valencia. Throughout her research career, she has developed her research in different fields, but always in the environment of rare diseases.
She obtained her PhD at the Institute of Biomedicine of Valencia (IBV, CSIC) in the field of genetics and comparative functional genomics of cerebellar ataxias under the direction of Dr. Palau. As a postdoc, at the same IBV and later at the Príncipe Felipe Research Center, she successfully initiated a new line of research to study the role of mitochondria in human disease and neurodegeneration. During this time, she made stays in prestigious centers such as the University of Cambridge or Cancer Research UK.
Since 2007 she has been a researcher at the CIBER of Rare Diseases, and from 2016 she joined as an associate researcher at INCLIVA, as part of the Cellular and Organic Pathophysiology of Oxidative Stress Research Group led by Dr. Federico Pallardó. In the last 11 years she has obtained, uninterruptedly, her own funding as Principal Investigator. Research grants are included in different state and regional competitive programs, both public and private, as well as service contracts with private companies.
She is currently an associate professor in the Department of Physiology of the Faculty of Medicine and Dentistry of the University of Valencia.